Mrs. Sioe could not get out of bed after her fifth round of chemotherapy. She could only sit up for a short time.
A PET-CT scan on September 18, 2013, revealed a recurrence mass at the site of her previous stomach surgery, along with metastasis to the brain. An earlier MRI had already shown spread to both the right and left cerebellum, measuring 1-2 cm, which made it difficult for her to wake up.
Three months earlier, Mrs. Sioe had been diagnosed with stomach cancer. She underwent surgery to remove a cancer mass that took up about one-third of her stomach. Following the surgery, she underwent six rounds of chemotherapy.
Before finishing chemotherapy, the cancer in her stomach reappeared near the surgical site, accompanied by brain metastasis. Her condition continued to decline.
Knowing that her mother’s cancer could not be controlled by surgery and chemotherapy, Mrs. Sioe’s son began looking for alternative treatments. By the end of September 2013, he easily found ECCT, which was gaining popularity in the media. He disregarded the controversies surrounding it at that time in the medical community and among the general public.
He obtained an ECCT device in the form of an abdominal corset and a helmet for his mother, recommended to be worn for 4×2 hours each day.
The reactions after a few days of use were quite intense: she experienced green and black stools with a very foul odor, constant flatulence with an unpleasant smell, sticky and pungent sweat, and cloudy, very foul-smelling urine.
As the extreme elimination reactions occurred, Mrs. Sioe’s condition rapidly improved. A week after starting the device, she was able to sit up for longer periods. After two weeks, she could stand and walk again.
She still had one more chemotherapy session to complete and continued using the device after finishing all her chemotherapy.
One month after starting the device, her condition was relatively normal. She had started to gain weight, and her pain and headaches had significantly decreased without the use of painkillers, although she still occasionally felt weak.
A PET scan after 1.5 years of using the device (May 2015) showed she was declared CLEAR. Her general condition was also normal, with relatively no complaints. Mrs. Sioe continued using the device for another year as a preventive measure.
After a long period without updates, in July 2023, Mrs. Sioe returned, accompanied by her son. She complained of experiencing vertigo. A CT scan revealed a new mass measuring 2 cm in her cerebellum.
She received the latest device to cover the newly emerged tumor in her brain. This new device was recommended for use for 2×2 hours, starting with a half-hour session. However, this time, Mrs. Sioe also received a vest device for preventive care for her abdomen, lungs, and liver. Her complaints lasted only a short time after using the device again, and her headache and vertigo disappeared.
Wishing continued health for Mrs. Sioe.
About ECCT:
https://c-techlabs.com/electro-capacitive-cancer-therapy-ecct-devices/